Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios-Athanassios Dimopoulos

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Blood Reviews|December 4, 2010
Lenalidomide: an update on evidence from clinical trialsMeletios-Athanassios Dimopoulos, Evangelos Terpos
Expert Opinion on Pharmacotherapy|June 17, 2005
Current treatment options for myelomaEvangelos Terpos, Amin Rahemtulla, Meletios-Athanassios Dimopoulos
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Bortezomib in multiple myelomaEvangelos Terpos, Maria Roussou, Meletios-Athanassios Dimopoulos
Cancer Treatment Reviews|November 21, 2007
Aurora kinases as targets for cancer therapyGiannis Mountzios, Evangelos Terpos, Meletios-Athanassios Dimopoulos
Blood|September 5, 2009
A new pet for myelomaMeletios-Athanassios Dimopoulos, Lia A Moulopoulos, Evangelos Terpos
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2017
New Agents in Multiple Myeloma: An Examination of Safety ProfilesSara Bringhen, Edwin De Wit, Meletios-Athanassios Dimopoulos
Leukemia & Lymphoma|June 7, 2006
Clinical implications of chromosomal abnormalities in multiple myelomaEvangelos Terpos, Vangelis Eleutherakis-Papaiakovou, Meletios-Athanassios Dimopoulos
Expert Opinion on Biological Therapy|February 25, 2009
Applications of monoclonal antibodies for the treatment of hematological malignanciesMagda Migkou, Meletios-Athanassios Dimopoulos, Maria Gavriatopoulou, et al.
Blood|May 15, 2007
Myeloma bone disease and proteasome inhibition therapiesEvangelos Terpos, Orhan Sezer, Peter Croucher, et al.
Leukemia & Lymphoma|April 10, 2008
Novel anti-myeloma agents and angiogenesisKonstantinos Anargyrou, Meletios-Athanassios Dimopoulos, Orhan Sezer, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Blood Reviews|December 4, 2010
Lenalidomide: an update on evidence from clinical trialsMeletios-Athanassios Dimopoulos, Evangelos Terpos
Expert Opinion on Pharmacotherapy|June 17, 2005
Current treatment options for myelomaEvangelos Terpos, Amin Rahemtulla, Meletios-Athanassios Dimopoulos
Expert Opinion on Drug Metabolism & Toxicology|May 20, 2008
Bortezomib in multiple myelomaEvangelos Terpos, Maria Roussou, Meletios-Athanassios Dimopoulos
Cancer Treatment Reviews|November 21, 2007
Aurora kinases as targets for cancer therapyGiannis Mountzios, Evangelos Terpos, Meletios-Athanassios Dimopoulos
Blood|September 5, 2009
A new pet for myelomaMeletios-Athanassios Dimopoulos, Lia A Moulopoulos, Evangelos Terpos
Clinical Lymphoma, Myeloma & Leukemia|June 12, 2017
New Agents in Multiple Myeloma: An Examination of Safety ProfilesSara Bringhen, Edwin De Wit, Meletios-Athanassios Dimopoulos
Leukemia & Lymphoma|June 7, 2006
Clinical implications of chromosomal abnormalities in multiple myelomaEvangelos Terpos, Vangelis Eleutherakis-Papaiakovou, Meletios-Athanassios Dimopoulos
Expert Opinion on Biological Therapy|February 25, 2009
Applications of monoclonal antibodies for the treatment of hematological malignanciesMagda Migkou, Meletios-Athanassios Dimopoulos, Maria Gavriatopoulou, et al.
Blood|May 15, 2007
Myeloma bone disease and proteasome inhibition therapiesEvangelos Terpos, Orhan Sezer, Peter Croucher, et al.
Leukemia & Lymphoma|April 10, 2008
Novel anti-myeloma agents and angiogenesisKonstantinos Anargyrou, Meletios-Athanassios Dimopoulos, Orhan Sezer, et al.
Pageof 6